









Markets
/
Stocks
/
nasdaq-upc
/

Universe Pharmaceuticals Inc

UPC

4.290USD

+0.560+15.01%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

2.42MMarket Cap

0.00P/E TTM



Universe Pharmaceuticals Inc

4.290

+0.560+15.01%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Universe Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-92.21%-7.08M

-150.63%-2.43M

50.38%-3.68M

-21.57%4.80M

---7.42M

--6.12M

Net income from continuing operations

174.57%4.37M

-1731.28%-13.10M

39.16%-5.87M

-141.31%-715.43K

---9.64M

--1.73M

Operating gains losses

-5.63%236.87K

-3.46%248.86K

3.79%251.00K

-11.75%257.78K

--241.84K

--292.11K

Deferred tax

-193.03%-58.44K

19.44%665.15K

114.21%62.83K

654.62%556.87K

---441.97K

---100.41K

Other non-cash items

-1388.48%-2.61M

1209.33%2.79M

-67.74%202.72K

58.88%-251.89K

--628.31K

---612.53K

Change in working capital

-184.23%-1.40M

-113.21%-653.92K

-7.06%1.67M

3.02%4.95M

--1.79M

--4.81M

-Change in receivables

-76.14%1.64M

-89.70%-3.35M

1264.48%6.87M

42.36%-1.76M

--503.75K

---3.06M

-Change in inventory

332.58%1.62M

105.43%26.55K

-179.25%-695.08K

43.20%-488.75K

--877.10K

---860.52K

-Change in prepaid expenses

-243.05%-1.34M

53.64%-189.36K

455.58%934.56K

-104.12%-408.43K

---262.83K

--9.91M

Cash from non-recurring investing activities

Cash from operating activities

-92.21%-7.08M

-150.63%-2.43M

50.38%-3.68M

-21.57%4.80M

---7.42M

--6.12M

Investing cash flow

Net cash from continuing investing activities

574.63%293.62K

4573.22%30.19K

14.27%43.52K

-98.83%646.00

--38.09K

--55.09K

Capital expenditures

578.77%295.42K

4573.22%30.19K

14.27%43.52K

-98.84%646.00

--38.09K

--55.63K

Net cash flow from disposal of fixed assets

305.14%176.33K

4573.22%30.19K

14.27%43.52K

-98.83%646.00

--38.09K

--55.09K

Net cash flow from intangible asset transactions

--117.29K

----

Net cash flow from investment products

----

--0.00

----

Net cash flow from other investing activities

---11.00

---37.47K

----

---3.81M

----

Cash from non-current investing activities

Net cash flow from investing activities

-574.65%-293.63K

-10373.07%-67.66K

98.87%-43.52K

98.83%-646.00

---3.85M

---55.09K

Financing cash flow

Cash flow from continuous financing activities

903.29%27.89M

191.59%6.07M

-204.00%-3.47M

10509.27%2.08M

--3.34M

---19.99K

Net cash flow from debt Issuance/repayment

183.15%2.89M

191.59%6.07M

-204.00%-3.47M

10509.27%2.08M

--3.34M

---19.99K

Net cash flow from common stock issuance/repurchase

--25.00M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

903.29%27.89M

191.59%6.07M

-204.00%-3.47M

10509.27%2.08M

--3.34M

---19.99K

Net cash flow

Beginning cash balance

-31.59%8.86M

-7.46%5.29M

-9.00%12.95M

-29.30%5.71M

--14.24M

--8.08M

Current period cash flow changes

369.08%20.64M

-50.62%3.58M

10.04%-7.67M

17.61%7.24M

---8.52M

--6.16M

Effect of exchange rate changes

125.45%120.20K

-98.38%5.89K

19.96%-472.25K

215.85%364.08K

---590.00K

--115.27K

Ending cash balance

458.11%29.50M

-31.59%8.86M

-7.46%5.29M

-9.00%12.95M

--5.71M

--14.24M

Free cash flow

-97.90%-7.37M

-151.27%-2.46M

50.05%-3.73M

-20.86%4.80M

---7.46M

--6.06M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

